JAPANESE CIRCULATION JOURNAL
Online ISSN : 1347-4839
Print ISSN : 0047-1828
ISSN-L : 0047-1828
Volume 60, Issue 3
Displaying 1-10 of 10 articles from this issue
Special Article
Clinical Study
  • Hideki Hashimoto, Tsutomu Tamura, Yuji Ikari, Kazuhiro Hara, Fumihiko ...
    Article type: None
    Subject area: None
    1996Volume 60Issue 3 Pages 142-148
    Published: 1996
    Released on J-STAGE: January 25, 2002
    JOURNAL FREE ACCESS
    The outcome of aortic balloon valvuloplasty (ABV) was compared with that of aortic valve replacement (AVR) in aortic stenosis (AS) patients more than 60 years old. The indications for ABV included low respiratory and renal function, cancer, the patient's refusal of surgery, and low daily activity. Twenty six patients underwent AVR and 13 underwent ABV. Initially, the AVR group was younger and more symptomatic than the ABV group. Two perioperative deaths occurred in the AVR group, while there were none in the ABV group. Twenty-four AVR patients and 12 ABV patients had a successful outcome, with remarkable pressure gradient reduction in both groups. In the follow-up, only 1 death and no cardiac events were detected in the AVR group (mean follow-up of 27 months), whereas 3 deaths, 6 heart failures, 2 repeated ABV, and 4 AVR were seen in the ABV group (mean follow-up of 10 months). The data showed that ABV was safer than AVR, but a higher rate of restenosis limited its efficacy. In the ABV group, a higher ratio of balloon size to aortic diameter correlated with longer event-free survival. We concluded that for elderly AS patients, ABV should be used only in those with high surgical risk as a palliative therapy or a bridge therapy to AVR, and AVR should be primarily recommended under rigid evaluation of the patient's physical status. (Jpn Circ J 1996; 60: 142 - 148)
    Download PDF (488K)
  • Special Reference to TAT/PIC and FPA/PIC
    Hitoshi Uenomachi, Masahiro Sonoda, Taiki Miyauchi, Narihito Harubyu, ...
    Article type: None
    Subject area: None
    1996Volume 60Issue 3 Pages 149-156
    Published: 1996
    Released on J-STAGE: January 25, 2002
    JOURNAL FREE ACCESS
    To clarify the relationship between the results of intracoronary thrombolytic therapy (ICT) and fibrino-coagulation in patients with acute myocardial infarction (AMI), the thrombin-antithrombin III complex (TAT) and fibrinopeptide A (FPA), as indices of accelerated coagulation, and the plasmin- α 2-plasmin inhibitor complex (PIC), as an index of accelerated fibrinolysis in peripheral blood, were measured just before and after heparin injection (5,000 U), and immediately after ICT. Twenty-four patients with AMI were divided into 2 groups according to the results of ICT; successful ICT (group S) and unsuccessful ICT (group F). As a control group (group C), 14 age-matched normal volunteers were also studied. The levels of TAT and FPA before ICT were significantly higher in groups S and F than in group C (p<0.01). The TAT level before ICT in group F was higher than that in group S (p=0.07), however, the TAT, FPA and PIC levels showed no significant differences between groups S and F at each sampling time. TAT/PIC before ICT was significantly higher in group F than in group S (F: 0.026±0.020 vs S: 0.008±0.004, p<0.05), whereas there was no remarkable difference in FPA/PIC between groups S and F. These results indicate that hyper-coagulation had occurred in the AMI cases and that coagulation had been more accelerated in group F. TAT/PIC might be an index of the equilibrium of the fibrino-coagulating system. Therefore, TAT/PIC measurement before thrombolytic therapy may be more useful than TAT measurement alone for evaluating recanalization in ICT. (Jpn Circ J 1996; 60: 149 - 156)
    Download PDF (576K)
Experimental Study
  • Shuji Ishida, Morio Ito, Naohiko Takahashi, Takao Fujino, Tadafumi Aki ...
    Article type: None
    Subject area: None
    1996Volume 60Issue 3 Pages 157-165
    Published: 1996
    Released on J-STAGE: January 25, 2002
    JOURNAL FREE ACCESS
    Caffeine induces delayed afterdepolarizations (DADs) and triggered activity in isolated cardiac tissue. We investigated the ability of caffeine to induce triggered ventricular arrhythmias in rabbits in vivo. During continuous infusion of caffeine at doses of 0.3 or 1.0 mg/kg per min, ventricular pacing was performed with 50 stimuli with a cycle length of 220 msec (basic pacing train) every 5 min until ventricular tachycardia (VT) was induced. The effects of programmed stimulation and pharmacologic agents on the induction of ventricular ectopic beats (VEBs) were examined. Pacing protocols were carried out in the presence of vagal-induced slowing of sinus rhythm. VT was induced by a basic pacing train during the infusion of caffeine at 1.0 mg/kg per min, but not at 0.3 mg/kg per min. An increase in the pacing rate or the number of stimuli resulted in 1) a decrease in the first postpacing interval, and 2) an increase in the number of postpacing VEBs. Induction of VT was suppressed by intravenous bolus injections of verapamil, propranolol and adenosine. At the time of the initial induction of VT, the plasma concentration of caffeine was 87±2 μg/ml and the plasma level of norepinephrine increased from 666±166 pg/ml at baseline to 1121±245 pg/ml. These results suggest that catecholamine-associated triggered activity may be responsible for caffeine-induced VT. (Jpn Circ J 1996; 60: 157 - 165)
    Download PDF (708K)
Case Report
  • Hiroshi Shionoiri, Izumi Takasaki, Nobuhito Hirawa, Minoru Kihara, Eij ...
    Article type: None
    Subject area: None
    1996Volume 60Issue 3 Pages 166-170
    Published: 1996
    Released on J-STAGE: January 25, 2002
    JOURNAL FREE ACCESS
    We describe a rare case of ACE inhibitor-induced angioedema during long-term therapy in a 51-year-old male patient with essential hypertension; and this is the third case reported of this adverse reaction in Japan. The patient received enalapril for 66 months, and complained of a dry cough which was mild and tolerable. Recently, he noted tenderness of his mouth, face, swelling of lips and tongue for 3 to 4 h after taking his morning dose of enalapril. These symptoms abated spontaneously, so he continued taking the drugs. He again noted similar episodes of angioedema 29 days after the first experience. He had no further episodes of angioedema or dry cough after cessation of enalapril. This case of angioedema developed during long-term therapy with enalapril administered as 19,930 mg of enalapril maleate. We emphasize that angioedema may occur at any time during the use of enalapril. (Jpn Circ J 1996; 60: 166 - 170)
    Download PDF (582K)
  • Masatoshi Ikeshita, Noboru Yamate, Shigeo Tanaka, Tetsuo Asano, Atsush ...
    Article type: None
    Subject area: None
    1996Volume 60Issue 3 Pages 171-176
    Published: 1996
    Released on J-STAGE: January 25, 2002
    JOURNAL FREE ACCESS
    A 46-year-old woman with mitral stenosis, WPW syndrome, hemolytic anemia due to spherocytosis, and hypothyroidism with Hashimoto's thyroiditis, was admitted with palpitations and dyspnea due to paroxysmal atrial fibrillation with a rapid ventricular response, and was treated by electrical cardioversion. We selected surgical intervention to treat the mitral stenosis and WPW syndrome, as some tachycardia episodes due to atrial fibrillation have resulted in repeated congestive heart failure. In 1983 we simultaneously performed a division of the posteroseptal accessory pathway and a mitral valve replacement with a biopros-thetic valve under cardiopulmonary bypass, using a membrane oxygenator after splenectomy to compensate for the hemolytic anemia due to spherocytosis. Her postoperative course was favorable and she is now in good health with no episodes of tachycardia, congestive heart failure nor anemia occurring during the 10 years that have followed the operation. Simultaneous surgery for WPW syndrome combined with other cardiac abnormalities and hematologic disorders achieved acceptable results in this case. (Jpn Circ J 1996; 60: 171 - 176)
    Download PDF (670K)
  • Takaki Sugimoto, Kyoichi Ogawa, Tatsuro Asada, Nobuhiko Mukohara, Tets ...
    Article type: None
    Subject area: None
    1996Volume 60Issue 3 Pages 177-180
    Published: 1996
    Released on J-STAGE: January 25, 2002
    JOURNAL FREE ACCESS
    A 63-year-old male was operated on for chronic heart failure due to myocardial ischemia and constrictive pericarditis after heart surgery. He was in New York Heart Association (NYHA) class III under a large dose of diuretics. He underwent a pericardiectomy and coronary bypass surgery without cardiopulmonary bypass. His cardiac function improved with a patent graft. He is now, 1 year after surgery, in NYHA class I under a tapering dose of diuretics. (Jpn Circ J 1996; 60: 177 - 180)
    Download PDF (795K)
  • A Case Report
    Yuji Sakanoue, Kanji Iga, Chisato Izumi, Tadashi Miyamoto, Takahisa Ki ...
    Article type: None
    Subject area: None
    1996Volume 60Issue 3 Pages 181-184
    Published: 1996
    Released on J-STAGE: January 25, 2002
    JOURNAL FREE ACCESS
    We present a 74-year-old female in whom a systolic murmur became trans-systolic during the Valsalva maneuver. The patient had had stable effort angina for 20 years and coronary angiography revealed complete obstruction of the left anterior descending artery in addition to other atherosclerotic lesions. Left ventriculography showed a small apical aneurysm with a narrow orifice. Aorto-coronary bypass surgery and aneurysm-ectomy were performed; true aneurysm was confirmed pathologically. We conclude that apical aneurysm with a narrow orifice can produce trans-systolic murmur. (Jpn Circ J 1996; 60: 181 -184)
    Download PDF (1183K)
  • Shuichi Yano, Kazue Shimada
    Article type: None
    Subject area: None
    1996Volume 60Issue 3 Pages 185-188
    Published: 1996
    Released on J-STAGE: January 25, 2002
    JOURNAL FREE ACCESS
    We report here a case of vasospastic angina following the administration of Carboplatin (CBDCA) and Etoposide (VP-16) in a patient with small cell lung carcinoma. Although these drugs are commonly used to treat small cell lung carcinoma, there has been no previous report of vasospastic angina in a patient without a history of heart disease. Therefore, we should be aware of the possibility that vasospastic angina may develop even in a patient without any history of heart disease. While calcium antagonist and isosorbide dinitrate are generally helpful for preventing vasospastic angina, these drugs could not completely suppress vasospastic angina in this case. (Jpn Circ J 1996; 60: 185 - 188)
    Download PDF (591K)
  • Takashi Kurita, Tohru Ohe, Kazuisa Maeda, Fumitaka Isobe, Shiro Kamaku ...
    Article type: None
    Subject area: None
    1996Volume 60Issue 3 Pages 189-191
    Published: 1996
    Released on J-STAGE: January 25, 2002
    JOURNAL FREE ACCESS
    The present patient demonstrated torsade de pointes (TdP) after a pacemaker implantation without a decrease in heart rate or pacemaker malfunction. Marked QT prolongation and TdP were closely related to alteration of the depolarization pattern (appearance of junctional rhythm). Resetting the pacemaker to a rate that inhibited spontaneous rhythm was effective in preventing TdP. (Jpn Circ J 1996; 60: 189 - 191)
    Download PDF (197K)
feedback
Top